Welcome to our dedicated page for Nuvei Corporation news (Ticker: $NVEI), a resource for investors and traders seeking the latest updates and insights on Nuvei Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nuvei Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nuvei Corporation's position in the market.
Nuvei announced the filing of a Management Proxy Circular and received an interim order for a go-private transaction involving Advent International. Shareholders will receive $34.00 per share, a 56% premium on the last trading day before media reports of the transaction. The Board recommends shareholders vote for the arrangement at a special meeting on June 18, 2024. The interim order authorizes the meeting and other related matters. The arrangement must be approved by a detailed voting process. Full details are available on SEDAR and EDGAR.
Nuvei reported its financial results for the first quarter of 2024, showing significant growth in total volume, revenue, and adjusted EBITDA. The company also announced a cash dividend and a proposed transaction to be taken private by Advent International. Revenue increased across all geographies, and the company plans to delist from stock exchanges after the transaction.